Pharmaceuticals industry
Download
1 / 15

Pharmaceuticals Industry - PowerPoint PPT Presentation


  • 262 Views
  • Uploaded on

Pharmaceuticals Industry. Cogent and Pharmaceuticals . Pharmaceutical Industry. Pharmaceutical Industry: “Traditional” branch Research = Discovery: new “small” organic molecules (years) Deep competence in drug discovery via Organic Chemistry

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about 'Pharmaceuticals Industry' - mike_john


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
Pharmaceuticals industry l.jpg

Pharmaceuticals Industry

Cogent and Pharmaceuticals


Pharmaceutical industry l.jpg
Pharmaceutical Industry

  • Pharmaceutical Industry: “Traditional” branch

    • Research = Discovery: new “small” organic molecules (years)

    • Deep competence in drug discovery via Organic Chemistry

    • Development: pre-clinical & clinical testing and approval (10 years)

    • Commercialisation (during Patent lifetime; 20 years)

    • Issues: regulations & approvals; high drug attrition rate; manufacturing costs; national markets e.g., NHS; pipeline value- innovation; international competition incl. Emerging markets

  • Bio-Pharma: Non-”traditional” branch

    • Very large biological molecules-bio-pharmaceuticals (nucleic acids, proteins)

    • Fundamental understanding of human biology and diseases: R&D cutting edge: Big Science

    • Many SMEs and micros: start-ups, University spin-offs

    • Cash short; risky: Survival!!

    • But no escape from long timescale to commercialisation: technical and commercial symbiosis with traditional Pharma


  • Pharmaceuticals uk l.jpg
    Pharmaceuticals-UK

    • Largely SE, NW and NE England

      • £12bn exports; trade balance £3.5bn

      • 73,000 direct employees (27,000 in R&D); 250,000 related employees

      • £3.2 bn in UK-based R&D (25% of UK total R&D in manufacturing)

      • ~100 UK companies producing prescription medicines

      • UK: 80% all GP prescriptions written generically

      • Third most profitable UK , after tourism and finance


    Sector skills councils l.jpg
    Sector Skills Councils

    • Cogent footprint: “SIC Codes”

      • Manufacture of basic pharmaceutical products (24.41 {03}; 21.10 {08})

      • Manufacture of pharmaceutical preparations (24.42; new 21.20)

  • SEMTA: “Science” (not SIC based)

    • Research and Development

    • Bioscience

    • {There will now be (08) a R&D SIC 72.11 (bio) & 72.19 (Eng & Science)}

  • Other SSCs:

    • Skills for Health -pharmacy

    • Lantra -Animal Technologists

    • Improve – Food Technologists

    • SSDA –Pharmaceutical packaging


  • Cogent going forward l.jpg
    Cogent going forward

    • Re-licensing in 2008:

      • Rationalise the Science-Pharma and Bio-pharma interface

  • Post Leitch Review of UK Skills:

    • Cogent the only body to determine vocational Qualifications eligible for funding: Qualifications valued by employers

    • Sole “owner” of National Occupation Standards (NOS)

    • Sole owner of Apprenticeship Standards

  • National Skills Academy for the Processing Industries

  • Higher Education:

    • Emerging and critical area for SSCs generally


  • Current skills situation in pharmaceuticals l.jpg
    Current Skills Situation in Pharmaceuticals

    • Skills Gaps at Levels 2 to 4

      • Gaps = employee not fully proficient in current job role

      • Particular issue with Process and Plant Operatives roles

      • First line maintenance

      • Lean manufacture and continuous improvement

      • Rapid manufacture techniques

      • Basic chemistry/understanding of processes

      • Application of knowledge, including graduates’ practical and interpretative skills


    Current skills situation in pharmaceuticals7 l.jpg
    Current Skills Situation in Pharmaceuticals

    • Skills Shortages

      • Vacancies hard to fill due to lack of suitable candidates

      • Especially Level 4+, graduates in chemical and molecular biological sciences

      • The “omics” technologies; synthetic organic chemistry; clinical R&D

      • University courses declining in relevance

      • Analytical chemistry

      • ABPI Report: Sustaining the Skills Pipeline in the Pharmaceutical and Biopharmaceutical Industries; www.abpi.org.uk/Details.asp?ProductID=285




    Cogent process industries economic value of skills l.jpg
    Cogent Process Industries – Economic Value of Skills

    Source: DBERR, Value-Added Scorecard, 2007

    • Skills Intensity* Process Industries

      • High : Medium-High

      • c.f. Banking : Life Insurance

      • *measured as average employee cost

    • Skills and Productivity

    • Basic skills - employment

    • Medium skills (FE/HE) - productivity

    • Higher skills (HE) - sustainability

    Process Industry - in transition:

    • Value Added

    • Speciality Products

    • Process/Product Innovation

    • R&D


    Demographics skills education and training l.jpg
    Demographics, Skills, Education and Training

    • Leitch (2006/2007)

    • UK target as world leader in skills

    • SSCs as regulators of vocational FE

    • Close collaboration between SSCs and HE

    Education Headlines

    • 70% of 2020 workforce already >16 yrs of age

    • 12% decline in 18 yr olds 2010- 2020

    • 40% jobs will require graduate skills by 2020

    • 90% of 2+ A’L student in HE (50% Voc Quals)

    • UK 11 out 30 (OECD) attainment at Level 4

    • FE to have FD-awarding status

    • all 16-18 yr olds to be in educ OR training?


    Pharma s response l.jpg
    Pharma’s Response

    • Response part of overall business requirements/pressures

      • Costs; international competition; M&A; licensing, regulatory, etc

      • Large organisations becoming leaner, flatter

      • Less middle-management, more empowered, higher-skilled operational and technical workforce needed

      • Majors have tradition of in-house training

      • Small and micro companies: rely on Higher Education; other methods poorly utilised

  • Other options are to recruit from immigrant population or move manufacturing and/or R&D abroad


  • Industry response c t d l.jpg
    Industry Response, c’t’d

    • Pharma companies and their Trade Associations are engaging with the public skills infrastructure-however it’s cluttered and complicated!

      • Schools, Colleges- out-reach and influencing teaching and content

      • HE: notoriously tough to change their cultures

      • Regional and national entities: RDAs, Business support networks, Government agencies such as Learning and Skills Councils

  • Self-organised networks are addressing, inter alia skills

    • E.g., ABPI nationally; NEPIC in NE; Biopharma and Health Technologies Employer Consortium in SE

    • Networks are of variable strength regionally; many quite lean

    • Networks want joined-up offering from all providers and agencies


  • Cogent s role l.jpg
    Cogent’s role

    • In-depth projects, based on deep knowledge of vocational (and soon higher education) provision and mechanisms, to understand and develop solutions for Pharmaceutical and Bio-pharma employers, employees and education and training providers

      • including close collaboration with SEMTA and fdf

    • The existing workforce: demographics are: 75% of today’s workforce will still be employed in 2010

      • Cogent Gold Standard for up-skilling the existing pharmaceutical workforce

    • Entering workforce:

      • Apprenticeship framework (Level 3)

      • Career pathways: attraction of talent from school age onwards

      • Higher Education: Level 4+

        • Foundation degrees, articulated to Honours Degrees

        • New Cogent team for Higher Education in 2008


    Cogent s role c t d l.jpg
    Cogent’s role- c’t’d

    • Vocational Qualifications: understanding employer needs and translating into qualifications that employers value

      • Relevant: practical skills combined with underpinning knowledge

      • Progressive: life-long learning and upskilling

      • Flexible (modular) provision at work and in classroom

      • Secure funding from Government for Cogent-approved qualifications

      • Articulation to honours degree via Foundation Degrees

  • National Skills Academy for Process Industries

    • Quality assure provision of all training products and qualifications

    • Meet individual employers’ individual needs

    • Shared Skills Needs Database with Cogent for continuing relevance of all training and education of pharmaceutical employees

  • Skills Brokerage Service: First point of call for any employer

    • Train to Gain; BIT; but not only these- skills diagnosis and sign-posting to all provision


  • ad